Hearing Loss Trial, Recruiting NCT06960616 Sponsor: Massachusetts Eye and Ear Infirmary Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT06960616
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You became deaf or lost significant hearing after you had already learned to speak and understand language (not deaf from birth or early childhood)
  • You are 18 years of age or older
  • You are a new cochlear implant recipient using a device made by Cochlear Americas, and you have been identified before your device is switched on for the first time
  • You are able to complete follow-up tasks, such as repeating words or sentences, responding when you hear a sound, and filling out questionnaires
  • You are an English speaker

Who may not be able to join:

  • You have chosen a cochlear implant made by a different manufacturer (other than Cochlear Americas)
  • You were deaf from birth or lost your hearing before you learned to speak and understand language
  • You have multiple disabilities (confirm with trial site)
  • You are not able to complete follow-up tasks such as repeating words or sentences, responding when you hear a sound, or filling out questionnaires
  • You do not speak English
  • You are under the age of 18

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Julie Arenberg, Massachusetts Eye and Ear

Phone: 6178077904

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Massachusetts Eye and Ear Infirmary
Registry
ClinicalTrials.gov
Start date
27 February 2024
Est. completion
26 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Speech perception scores; Duration of programming session

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov